Triptorelin (Trelstar, Decapeptyl) studies: 345 papers with results
Page 2 of 7
- [Multicentre randomized trial comparing triptorelin medical castration versus surgical castration in the treatment of locally advanced or metastatic prostate cancer].
Botto H · Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie · 2007
Randomized controlled trial · 3 results
- Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
Kang JL · Gynecologic and obstetric investigation · 2010
Randomized controlled trial · 7 results
- A randomized comparison of the clinical and hormonal effects of two GnRH agonists in patients with prostate cancer.
Kuhn JM · European urology · 1997
Randomized controlled trial · 3 results
- [Efficacy and safety of long-acting gonadotropin-releasing hormone analogue in the treatment for metastatic prostate cancer].
Li NC · Zhonghua wai ke za zhi [Chinese journal of surgery] · 2008
Randomized controlled trial · 10 results
- GnRH agonist treatment before total laparoscopic hysterectomy for large uteri.
Seracchioli R · The Journal of the American Association of Gynecologic Laparoscopists · 2003
Randomized controlled trial · 2 results
- Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults.
Cassio A · The Journal of pediatrics · 2006
Randomized controlled trial · 1 result
- Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF.
Yim SF · Human reproduction (Oxford, England) · 2001
Randomized controlled trial · 7 results
- Prospective randomized study of D-Trp6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles.
Gianaroli L · Human reproduction (Oxford, England) · 1994
Randomized controlled trial · 18 results
- Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical Trial.
Østergren PB · The Journal of urology · 2017
Randomized controlled trial · 4 results
- A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis.
Cirkel U · European journal of obstetrics, gynecology, and reproductive biology · 1995
Randomized controlled trial · 7 results
- A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis.
Loverro G · European journal of obstetrics, gynecology, and reproductive biology · 2008
Randomized controlled trial · 5 results
- Dual trigger vs. gonadotropin-releasing hormone agonist trigger for elective fertility preservation: a randomized controlled trial.
Donno V · Fertility and sterility · 2026
Randomized controlled trial · 8 results
- Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study.
Orvieto R · Fertility and sterility · 2002
Randomized controlled trial · 9 results
- Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression.
Melli MS · Saudi medical journal · 2007
Randomized controlled trial · 2 results
- Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF.
Janssens RM · Human reproduction (Oxford, England) · 1998
Randomized controlled trial · 3 results
- Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Munster PN · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2012
Randomized controlled trial · 2 results
- Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty.
Liang Y · Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2006
Randomized controlled trial · 15 results
- Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation.
Sonntag B · Journal of assisted reproduction and genetics · 2004
Randomized controlled trial · 8 results
- [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
Liang Y · Zhonghua er ke za zhi = Chinese journal of pediatrics · 2004
Randomized controlled trial · 17 results
- Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide.
Karimi-Zarchi M · European journal of gynaecological oncology · 2014
Randomized controlled trial · 6 results
- An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis.
Wong AY · Fertility and sterility · 2004
Randomized controlled trial · 5 results
- Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial.
Zarcos SM · JBRA assisted reproduction · 2017
Randomized controlled trial · 5 results
- Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist.
Giampietro F · Fertility and sterility · 2006
Randomized controlled trial · 11 results
- Short term pituitary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin.
Broekmans FJ · Human reproduction (Oxford, England) · 1996
Randomized controlled trial · 2 results
- Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin.
Falkson CI · Oncology · 1996
Randomized controlled trial · 5 results
- Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study.
Bouvattier C · The Journal of clinical endocrinology and metabolism · 1999
Randomized controlled trial · 4 results
- Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up.
Bständig B · Journal of assisted reproduction and genetics · 2000
Randomized controlled trial · 3 results
- Risk of recurrent menorrhagia after hydrothermoablation: role of GnRH analogues neoadjuvant treatment in long-term successful rate.
Litta P · Clinical and experimental obstetrics & gynecology · 2014
Randomized controlled trial · 3 results
- Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy.
Broekmans FJ · American journal of obstetrics and gynecology · 1996
Randomized controlled trial · 6 results
- Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I · The Journal of reproductive medicine · 2008
Randomized controlled trial · 3 results
- Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulatory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles.
Shalev E · Human reproduction (Oxford, England) · 1995
Randomized controlled trial · 6 results
- Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes.
Sayyah-Melli M · Saudi medical journal · 2009
Randomized controlled trial · 8 results
- Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
Carmina E · The Journal of clinical endocrinology and metabolism · 1994
Randomized controlled trial · 17 results
- Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years.
Cassio A · Archives of disease in childhood · 1999
Randomized controlled trial · 8 results
- Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
Celio L · Anticancer research · 1999
Randomized controlled trial · 15 results
- Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.
Abbara A · Fertility and sterility · 2024
Randomized controlled trial · 2 results
- The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers.
Martinetti A · The Journal of steroid biochemistry and molecular biology · 2000
Randomized controlled trial · 15 results
- Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease.
Schaison G · Hormone research · 1987
Randomized controlled trial · 8 results
- A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME · Fertility and sterility · 2010
Randomized controlled trial · 2 results
- A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis.
Alborzi S · Archives of gynecology and obstetrics · 2011
Randomized controlled trial · 4 results
- Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomata.
Golan A · Human reproduction (Oxford, England) · 1993
Randomized controlled trial · 3 results
- Luteal phase defects following agonist-triggered ovulation: a patient-dependent response.
Emperaire JC · Reproductive biomedicine online · 2004
Randomized controlled trial · 5 results
- Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
Pazos F · Fertility and sterility · 1999
Randomized controlled trial · 4 results
- Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
Antoniazzi F · The Journal of clinical endocrinology and metabolism · 1999
Randomized controlled trial · 15 results
- Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial.
Najafi S · BMC cancer · 2023
Randomized controlled trial · 10 results
- Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer.
Lebret T · Therapeutic advances in urology · 2015
Non-randomized trial · 8 results
- Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study.
Lundström EA · Clinical drug investigation · 2009
Non-randomized trial · 5 results
- Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
Carel JC · European journal of endocrinology · 2006
Non-randomized trial · 10 results
- Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty.
Klein K · Journal of pediatric endocrinology & metabolism : JPEM · 2016
Non-randomized trial · 3 results
- Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment.
Roulier R · Reproductive biomedicine online · 2003
Non-randomized trial · 6 results